REDMILE GROUP, LLC Stoke Therapeutics, Inc. Transaction History

REDMILE GROUP, LLC portfolio value:

$10.73M
portfolio value

REDMILE GROUP, LLC quarter portfolio value change:

-2.80%
quarter

Stoke Therapeutics, Inc. 13F transactions

Quarter Transaction type Change Relative change Absolute change Change value Avg. price Shares
Q3 2022 share Decrease -58.07% -1.15M shares -15.59M $12.84 835.83K
Q2 2022 share Decrease -1.54% -31.1K shares -16.28M $13.21 1.99M
Q1 2022 share Decrease -9.89% -222.3K shares -11.28M $21.05 2.02M
Q4 2021 share Decrease -5.68% -135.29K shares -6.69M $24.07 2.24M
Q3 2021 share Decrease -3.12% -76.6K shares -22.15M $25.44 2.38M
Q2 2021 share Decrease -3.36% -85.50K shares -16.05M $33.66 2.45M
Q1 2021 share Decrease -5.29% -142.17K shares -67.54M $38.84 2.54M
Q4 2020 share Increase +5.36% 136.72K shares 80.97M $61.93 2.68M
Q3 2020 share Increase +1.89% 47.2K shares 25.75M $33.49 2.54M
Q2 2020 share Increase +15.53% 336.36K shares 10.03M $23.83 2.50M
Q1 2020 share Increase +112.19% 1.14M shares 20.69M $22.9 2.16M
Q4 2019 share Increase +0.32% 3.3K shares 7.04M $28.32 1.02M
Q3 2019 share Decrease -0.42% -4.33K shares -7.94M $21.49 1.01M
Q2 2019 share Increase 0.00% 1.02M shares 29.80M $29.17 1.02M